Oracle Stock Under the Microscope: Political Trading, Analyst Upgrades, and a $24.7 Billion Cash Burn Ahead of Earnings

Oracle heads into next week’s fiscal fourth-quarter earnings report with a stock that has swung wildly – up 30% in three sessions, then hammered nearly 5% in a single day. The whipsaw reflects a market trying to reconcile sky-high analyst targets with a staggering $24.7 billion negative free cash flow and a fresh political stock-disclosure headache.

A disclosure from US Senator Sheldon Whitehouse has added an unwelcome governance layer to the narrative. Whitehouse reported a sale of Oracle shares worth between $15,001 and $50,000, executed on May 7 and filed with the Senate on June 2. While the amount is modest and the senator has also disclosed trades in Nvidia, JPMorgan Chase, and PepsiCo, the timing – just days before a pivotal earnings release – invites scrutiny of trading activity around political figures. The sale is not an insider trade in the corporate sense, but it feeds into a broader sensitivity around stock movements when expectations are already elevated.

On Wednesday, Oracle shares traded in Europe at €199.20, down 5.26%, after falling roughly 4-5% in New York on Tuesday. The stock remains up 29.18% over the past 30 days, but volatility has spiked: the annualized 30-day figure stands at 70.16%. The RSI sits at 67.9, and the share price is 12.28% above its 200-day moving average – a technical setup that leaves little room for disappointment.

All eyes are on June 10, when Oracle reports quarterly results after the US close, followed by a conference call at 4:00 p.m. Central Time. The consensus from 42 analysts calls for earnings per share of $1.95 to $1.96 on revenue of roughly $19.10 billion. That would represent a 15% year-over-year EPS increase and 20% revenue growth – high bars that reflect the market's belief in Oracle's cloud and AI infrastructure story.

Should investors sell immediately? Or is it worth buying Oracle?

That belief was reinforced in recent days as several banks raised their price targets. UBS analyst Karl Keirstead lifted his target to $285 from $250, maintaining a "Buy" rating and citing sustained customer demand for AI and cloud services. Mizuho kept its "Outperform" rating and $320 target, forecasting revenue growth accelerating to 34% from 17%. Scotiabank and Citigroup also bumped their targets to $290 and $320, respectively. Morgan Stanley stands as a notable dissenter: it held an "Equal Weight" rating but cut its target to $207 from $213, with a bear-case scenario of just $75.

But the optimism comes with a glaring asterisk. Oracle's free cash flow is deeply negative at -$24.7 billion, driven almost entirely by aggressive capital spending on AI data centers. Mizuho sees a turnaround ahead, with FCF turning positive around fiscal 2029 at roughly $4 billion and then surging to $36 billion the following year. Analyst Siti Panigrahi estimates Oracle will need to invest at least $80 billion over the next three years, though total financing needs should stay under $100 billion. That kind of spending is both the engine of growth and the source of risk – the market is betting that future cash flows will eventually justify today's capital outlay.

Against this backdrop, routine insider filings offer a counterpoint of corporate normality. Director Rona Fairhead received 2,114 shares through restricted stock units on May 31, with 58 shares withheld at $225.78 to cover taxes. Director Bruce Chizen also received 2,114 shares via RSUs, which vest fully on the first anniversary of the grant date. In the past 90 days, Oracle has recorded 13 Form-4 transactions – a typical pace for a large-cap company.

Oracle at a turning point? This analysis reveals what investors need to know now.

Investor sentiment is mixed. Marble Wealth disclosed a new position of 7,035 shares worth about $1.37 million. Meanwhile, Oracle manager Stuart Levey slashed his stake by roughly 81% in April. Institutional investors hold 42.44% of outstanding shares – a level that suggests large funds are still engaged, but not yet fully committed.

The June 10 earnings call will need to do more than just meet the numbers. Oracle must convince the market that its cloud growth rate justifies the enormous cash burn. Until then, the stock will remain a direct barometer of confidence in the company's AI bet – jostled by political headlines, insider filings, and investor nerves.

Ad

Oracle Stock: New Analysis - 4 June

Fresh Oracle information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Oracle analysis...

en | US68389X1054 | ORACLE | boerse | 69479883 |